Dacetuzumab
Dacetuzumab (also known as SGN-40 or huS2C6) is a humanized monoclonal antibody being developed for the treatment of CD40-positive cancers like non-Hodgkin's lymphoma and hematological malignancies. This drug was developed by Seattle Genetics, Inc.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Dacetuzumab
Dacetuzumab (also known as SGN-40 or huS2C6) is a humanized monoclonal antibody being developed for the treatment of CD40-positive cancers like non-Hodgkin's lymphoma and hematological malignancies. This drug was developed by Seattle Genetics, Inc.
has abstract
Dacetuzumab (also known as SGN ...... oped by Seattle Genetics, Inc.
@en
Il dacetuzumab o SGN-40 o huS2 ...... re del farmaco è l'antigene: .
@it
داستوزوماب هو جسم مضاد وحيد النسيلة بشري طورته لعلاج اللمفومة لاهودجكينية .
@ar
CAS number
880486-59-9
FDA UNII code
UT59FF4T5X
Wikipage page ID
12,597,710
page length (characters) of wiki page
Wikipage revision ID
945,525,725
Link from a Wikipage to another Wikipage
ATC prefix
none
@en
CAS number
ChemSpiderID
none
@en
mab type
mab
@en
molecular weight
source
zu/o
@en
synonyms
SGN-40
@en
target
type
mab
@en
UNII
UT59FF4T5X
@en
Verifiedfields
changed
@en
verifiedrevid
460,112,574
Watchedfields
changed
@en
wikiPageUsesTemplate
hypernym
comment
Dacetuzumab (also known as SGN ...... oped by Seattle Genetics, Inc.
@en
Il dacetuzumab o SGN-40 o huS2 ...... re del farmaco è l'antigene: .
@it
داستوزوماب هو جسم مضاد وحيد النسيلة بشري طورته لعلاج اللمفومة لاهودجكينية .
@ar
label
Dacetuzumab
@en
Dacetuzumab
@it
داستوزوماب
@ar